NEW YORK ( TheStreet) -- Amedisys (Nasdaq: AMED) hit a new 52-week low Tuesday as it is currently trading at $11.99, below its previous 52-week low of $12.64 with 70,304 shares traded as of 9:35 a.m. ET. Average volume has been 532,300 shares over the past 30 days.

Amedisys has a market cap of $433.6 million and is part of the health care sector and health services industry. Shares are down 60% year to date as of the close of trading on Monday.

Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population. The company has a P/E ratio of 5.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
  • Practice your AMED trading strategies and win cash in our stock game.

TheStreet Ratings rates Amedisys as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. You can view the full Amedisys Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Here's What Blackstone Bought and Sold in the Fourth Quarter

Here's What Blackstone Bought and Sold in the Fourth Quarter

Here's What Blackstone and KKR Are Buying

Here's What Blackstone and KKR Are Buying

Republican Sweep Poised to Agitate ACA-Vulnerable Health Care Services Stocks

Republican Sweep Poised to Agitate ACA-Vulnerable Health Care Services Stocks

Blackstone, KKR Unveil Second-Quarter Stock Picks

Blackstone, KKR Unveil Second-Quarter Stock Picks